US Patent 11241573 Percutaneous and transcutaneous peripheral neuromodulation
Patent 11241573 was granted and assigned to EBT Medical on February, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11241573 Percutaneous and transcutaneous peripheral neuromodulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
